Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
456K
-
Shares change
-
+40.3K
-
Total reported value, excl. options
-
$1.34M
-
Value change
-
+$145K
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$2.93
Significant Holders of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) as of Q2 2020
15 filings reported holding SLS - SELLAS Life Sciences Group, Inc. - Common Stock as of Q2 2020.
SELLAS Life Sciences Group, Inc. - Common Stock (SLS) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 456K shares
of 105M outstanding shares and own 0.43% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (159K shares), BlackRock Inc. (100K shares), GEODE CAPITAL MANAGEMENT, LLC (60.6K shares), Virtu Financial LLC (33.3K shares), Squarepoint Ops LLC (32.4K shares), Bank of New York Mellon Corp (16.1K shares), RENAISSANCE TECHNOLOGIES LLC (14.4K shares), WINTON GROUP Ltd (12.1K shares), DIMENSIONAL FUND ADVISORS LP (11.9K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.8K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.